 |
Phosphatidylinositol 3-Kinase “PI3K” Inhibitor |
|---|---|
| Trade Name | |
| Orphan Indication | Chronic lymphocytic leukemia |
| USA Market Approval | USA |
| USA Designation Date | 2010-11-02 00:00:00 |
| Sponsor | Semafore Pharmaceuticals;17338 Westfield Park Road, Suite 3;Westfield, Indiana, 46074 |
